IR vs LLY · P/E 49, rev $7.24B vs P/E 39, rev $65.18B
Ingersoll Rand Inc (IR) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Ingersoll Rand Inc (IR) is a specialty industrial machinery company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported IR revenue for 2024-12-31 was $7.24B. Net income was $846.3M. Revenue was up 5.2% from 2023-12-31 to 2024-12-31. IR currently screens at market cap $28.27B and trailing P/E 48.8.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
IR currently screens at market cap $28.27B and trailing P/E 48.8. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the IR and LLY stock pages for the full models.
Not investment advice.